论文部分内容阅读
ISL1 influencing epigenetic configuration at the ZEB1 promoter enables gastric cancer cell carcinoge
【机 构】
：
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Division of Gastr
【出 处】
：
第十二届国际胃癌学术会议
【发表日期】
：
2017年4期
其他文献
Background: As per GLOBOCAN 2012 Gastric cancer is one of the most common cancers worldwide.It is also one of the most common causes for cancer related mortality.The prognosis remains poor for this ca
Prognostic impact of tubular-papillar/poorly cohesive-Signet Ring Cell ratio in WHO mixed gastric ad
Local recurrence of a large gastric GIST despite adequate resection and adjuvant imatinib mesylate t
Critical analysis of the safety,short-term benefits and procedure-related morbidity of the Hyperther
The reduction of peripheral CD19+CD24h CD27+B cell frequency predicts clinical benefits in XELOX-tre
Survival outcomes of advanced gastric cancer patients who underwent neoadjuvant chemotherapy and gas
Influence of SLCO1B3 genetic polymorphisms on the incidence of adverse effects and trough plasma con
Background: Imatinib(Marketed as Glivec in USA and Gleevec in Europe)is a tyrosine kinase inhibitor(TKI),commonly used as a first-line therapy for treatment of Gastrointestinal Stromal Tumors(GIST)and
Background: TNM stage is based on the survival data of gastric cancer patients who underwent radical gastrectomy without neoadjuvant therapy.Whether it is fit for the patients after neoadjuvant chemot